Cyclobenzaprine (Flexeril) After Surgery: Usage and Safety
Cyclobenzaprine (brand name Flexeril) is a skeletal muscle relaxant commonly prescribed after orthopedic, spinal, and abdominal surgery to reduce painful muscle spasms. It works in the central nervous system rather than directly on the muscles. Understanding how to take it safely, what to expect, and how it interacts with other post-surgical medications helps you get the benefit while avoiding problems.
How Cyclobenzaprine Works and When to Take It
Cyclobenzaprine acts on alpha motor neurons in the brainstem to reduce muscle tone and spasm. It does not act directly on the muscles themselves. The drug is structurally related to tricyclic antidepressants (amitriptyline), which explains many of its side effects. It is effective for acute musculoskeletal spasm but has not been shown to benefit chronic muscle pain or spasticity from neurological conditions.
The standard dose is 5 mg three times daily or 10 mg three times daily. Starting at 5 mg reduces the intensity of drowsiness while providing meaningful spasm relief. An extended-release formulation (Amrix 15 mg or 30 mg) is taken once daily. Most patients notice reduced spasms within 1 to 2 hours of the first dose. Peak effect occurs at 3 to 8 hours.
Cyclobenzaprine is approved for short-term use only (2 to 3 weeks). The FDA labeling states that effectiveness beyond 2 to 3 weeks has not been demonstrated. Most post-surgical muscle spasms resolve within this timeframe as the surgical site heals. Prolonged use increases the risk of dependence, anticholinergic side effects, and withdrawal symptoms.
Take cyclobenzaprine at bedtime if daytime drowsiness is a problem. Many surgeons prescribe it as a nighttime-only medication (5 to 10 mg at bedtime) because the muscle relaxation and sedation improve sleep quality during the painful early recovery period. The half-life is 18 hours (range: 8 to 37 hours), so a bedtime dose provides some daytime muscle relaxation.
Side Effects and Drug Interactions
Drowsiness is the most common side effect, occurring in 29% to 39% of patients according to FDA prescribing information. Do not drive, operate machinery, or make important decisions during the first 48 hours of use. The sedation typically lessens after 2 to 3 days of consistent dosing as your body adjusts. Combining cyclobenzaprine with opioid pain medication, benzodiazepines, or alcohol multiplies the sedation effect and increases fall risk.
Dry mouth affects approximately 21% to 32% of patients due to the anticholinergic properties. Frequent sips of water, sugar-free lozenges, and saliva substitutes (Biotene) help manage this. Other anticholinergic effects include blurred vision (3% to 12%), constipation (1% to 3%), and urinary retention (rare but more common in men with enlarged prostate). These effects are dose-dependent and resolve when the medication is stopped.
Do not combine cyclobenzaprine with MAO inhibitors (phenelzine, tranylcypromine, selegiline), as this combination can cause hyperpyretic crisis (dangerously high body temperature), seizures, and death. MAO inhibitors must be stopped at least 14 days before starting cyclobenzaprine. Also use caution with tramadol and SSRIs/SNRIs (sertraline, duloxetine, venlafaxine), as the combination may increase serotonin syndrome risk.
Patients over 65 should use cyclobenzaprine with caution or avoid it entirely. The American Geriatrics Society Beers Criteria lists cyclobenzaprine as a potentially inappropriate medication for older adults because of strong anticholinergic effects, sedation, and increased fall risk. If prescribed for an older patient, the dose should start at 5 mg and rarely exceed 5 mg three times daily.
Maximizing Benefit and Tapering Off
Combine cyclobenzaprine with ice, gentle stretching, and position changes for optimal spasm relief. The medication reduces the spasm intensity, but physical strategies address the underlying trigger. For back surgery patients: lie on your back with pillows under your knees, or on your side with a pillow between your knees. For abdominal surgery: a pillow pressed firmly against the incision (splinting) during coughing or movement reduces the reflex muscle spasm.
Track your spasm frequency and severity daily. Most patients experience significant improvement by days 5 to 7 of consistent use. If spasms are not improving after 1 week of cyclobenzaprine at 10 mg three times daily, contact your surgeon. Persistent spasms may indicate a mechanical problem (hardware irritation, nerve compression, or hematoma) rather than simple post-surgical muscle guarding.
Stopping cyclobenzaprine does not require a gradual taper if you have used it for 2 to 3 weeks or less. Simply stop taking it when spasms resolve. If used for longer than 3 weeks, reduce the dose gradually over 3 to 5 days to avoid rebound muscle spasms and mild withdrawal symptoms (irritability, nausea, headache). Withdrawal effects are generally mild and self-limiting.
If cyclobenzaprine is too sedating, alternatives include methocarbamol (Robaxin), which causes less drowsiness, or tizanidine (Zanaflex), which is shorter-acting and better suited for spasms that worsen at specific times (e.g., nighttime or during physical therapy). Discuss alternatives with your surgeon rather than simply stopping the medication and tolerating spasms.
Can I take cyclobenzaprine with hydrocodone or oxycodone?
Yes, this combination is commonly prescribed after surgery, but it requires caution. Both drugs cause sedation, and the combined effect is greater than either alone. Take them at separate times if possible (e.g., opioid at 8 AM, cyclobenzaprine at noon). Do not take both at bedtime initially. Avoid driving or operating machinery when taking both. If you feel excessively sedated (difficulty staying awake, confusion, shallow breathing), skip the next cyclobenzaprine dose and contact your surgeon.
Will cyclobenzaprine show up on a drug test?
Cyclobenzaprine does not typically appear on standard urine drug screens. However, because of its structural similarity to tricyclic antidepressants, it can cause a false positive for tricyclic antidepressants on immunoassay-based screening tests. If this occurs, a confirmatory gas chromatography-mass spectrometry (GC-MS) test will distinguish cyclobenzaprine from actual tricyclic antidepressants. Inform the testing facility that you are taking cyclobenzaprine.
Is cyclobenzaprine addictive?
Cyclobenzaprine has low abuse potential and is not classified as a controlled substance by the DEA. However, some patients develop a psychological preference for the sedation and muscle relaxation effects, particularly if they have a history of substance use. Physical dependence (withdrawal symptoms upon stopping) can develop with prolonged use beyond 3 to 4 weeks. The FDA recommends limiting treatment to 2 to 3 weeks for this reason.
For patients
Get a personalized care plan.
This guide provides general information. For instructions tailored to your specific procedure, ask your provider about QR Rx care plans.
These medication guides are for educational purposes only and do not replace medical advice. Always follow your healthcare provider's specific medication instructions.
